Search

Author/Creator Brewster, Michael

1. Efficacy and safety of subcutaneous rituximab versus intravenous rituximab for first-line treatment of follicular lymphoma (SABRINA): a randomised, open-label, phase 3 trial. Issue 6 (June 2017)

Authors:
Davies, Andrew; Merli, Francesco; Mihaljević, Biljana; Mercadal, Santiago; Siritanaratkul, Noppadol; Solal-Céligny, Philippe; Boehnke, Axel; Berge, Claude; Genevray, Magali; Zharkov, Artem; Dixon, Mark; Brewster, Michael; Barrett, Martin; MacDonald, David
Journal:
Lancet
Issue:
Volume 4:Issue 6(2017)
Page Start:
e272
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Pharmacokinetics and safety of subcutaneous rituximab plus fludarabine and cyclophosphamide for patients with chronic lymphocytic leukaemia. (29th July 2015)

Authors:
Assouline, Sarit; Buccheri, Valeria; Delmer, Alain; Gaidano, Gianluca; McIntyre, Christine; Brewster, Michael; Catalani, Olivier; Hourcade‐Potelleret, Florence; Sayyed, Pakeeza; Badoux, Xavier
Journal:
British journal of clinical pharmacology
Issue:
Volume 80:Number 5(2015:Nov.)
Page Start:
1001
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Pharmacokinetics, exposure, efficacy and safety of obinutuzumab in rituximab‐refractory follicular lymphoma patients in the GADOLIN phase III study. Issue 9 (12th July 2019)

Authors:
Gibiansky, Ekaterina; Gibiansky, Leonid; Buchheit, Vincent; Frey, Nicolas; Brewster, Michael; Fingerle‐Rowson, Günter; Jamois, Candice
Journal:
British journal of clinical pharmacology
Issue:
Volume 85:Issue 9(2019)
Page Start:
1935
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Pharmacokinetics, safety, and efficacy of subcutaneous versus intravenous rituximab plus chemotherapy as treatment for chronic lymphocytic leukaemia (SAWYER): a phase 1b, open-label, randomised controlled non-inferiority trial. Issue 3 (March 2016)

Authors:
Assouline, Sarit; Buccheri, Valeria; Delmer, Alain; Gaidano, Gianluca; Trneny, Marek; Berthillon, Natalia; Brewster, Michael; Catalani, Olivier; Li, Sai; McIntyre, Christine; Sayyed, Pakeeza; Badoux, Xavier
Journal:
Lancet
Issue:
Volume 3:Issue 3(2016)
Page Start:
e128
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Phase III safety study of rituximab administered as a 90-minute infusion in patients with previously untreated diffuse large B-cell and follicular lymphoma. Issue 10 (October 2014)

Authors:
Dakhil, Shaker; Hermann, Robert; Schreeder, Marshall T.; Gregory, Stephanie A.; Monte, Marc; Windsor, Kevin S.; Hurst, Deborah; Chai, Akiko; Brewster, Michael; Richards, Paul
Journal:
Leukemia & lymphoma
Issue:
Volume 55:Issue 10(2014:Oct.)
Page Start:
2335
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗